批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/02/10 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/08/01 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2002/07/18 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2002/07/18 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1996/03/07 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/10/27 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/10/27 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/06/12 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/06/12 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/07/31 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE 剂型/给药途径:OINTMENT;OPHTHALMIC 规格:0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM 治疗等效代码:AT
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050065 |
002 |
NDA |
MAXITROL |
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
OINTMENT;OPHTHALMIC |
0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM |
Prescription |
Yes |
Yes |
AT |
Approved Prior to Jan 1, 1982
|
SANDOZ |
062938 |
001 |
ANDA |
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE |
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
OINTMENT;OPHTHALMIC |
0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM |
Prescription |
No |
No |
AT |
1989/07/31
|
PADAGIS US |
064063 |
001 |
ANDA |
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE |
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
OINTMENT;OPHTHALMIC |
0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM |
Prescription |
No |
No |
AT |
1994/07/25
|
BAUSCH AND LOMB |